BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 26
• 27
• 28
• 31

• Business

  Merck & Co., Inc. Anticipates Earnings per Share Growth in 2008; Reaffirms Long-Term, Double-Digit Compound Annual EPS Growth from 2005 to 2010, Excluding Certain Items

  December 4, 2007

   · 

  1 min read
• Drug Development

  Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Stem Cell Transplantation

  December 4, 2007

   · 

  3 min read
• BioMidwest

  Sorin Group S.p.A. Cardiac Rhythm Management Announces the First U.S. Enrollment in the Option Study

  December 4, 2007

   · 

  1 min read
• Deals

  Harvard Bioscience Inc. Divests the Majority of its Capital Equipment Business

  December 4, 2007

   · 

  1 min read
• Business

  Nitec Pharma AG Appoints Hans Fünfschilling as Chairman

  December 4, 2007

   · 

  1 min read
• Business

  LifeWave Signs Binding Distribution Contract in Italy

  December 4, 2007

   · 

  1 min read
• Business

  Meridian Co. Ltd.'s CSA Mark Leads to Distribution Agreement With Henry Schein Ash Arcona

  December 4, 2007

   · 

  1 min read
• Genetown

  Aspect Medical Systems, Inc. to Report Results of BRITE Major Depression Study on December 11, 2007

  December 4, 2007

   · 

  1 min read
• Business

  PregLem SA Announces CHF 36 Million Series B Funding

  December 4, 2007

   · 

  6 min read
• Drug Development

  Portola Pharmaceuticals, Inc. Initiates Phase II Clinical Program in Heart Attack Patients With Its Novel Antiplatelet Agent, PRT060128

  December 4, 2007

   · 

  3 min read